I am a Postdoctoral Research Fellow at Massachusetts General Hospital pursuing research in aging biology. My work focuses on cellular senescence, chronic inflammation, and age-related diseases, with the goal of developing mechanism-based interventions to improve healthspan. During my doctoral training at the University of Florida, I investigated next-generation PROTAC senolytics targeting anti-apoptotic BCL-2 family proteins to overcome limitations of existing therapies. Through collaborations with colleagues and mentors, I contributed to the development of selective senolytic strategies with improved efficacy and safety. As first author, I demonstrated that selective clearance of senescent cells suppresses liver inflammation and delays MASH-driven hepatocellular carcinoma, findings published in Nature Aging (2025). This work provided preclinical evidence supporting cellular senescence as a therapeutic target and established a foundation for developing targeted interventions against age-related diseases. I also contributed to studies showing that senescent cells exhibit exaggerated inflammatory responses to secondary stimuli, providing mechanistic insights into inflammaging and age-associated vulnerability to chronic inflammatory disorders. My current research investigates how stress-response pathways regulate senescence-associated inflammation and innate immune signaling. I aim to identify translatable strategies to mitigate chronic inflammation and promote healthy aging.